Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000891824 | SCV001035662 | likely benign | not provided | 2019-12-31 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000891824 | SCV004810470 | likely benign | not provided | 2024-03-01 | criteria provided, single submitter | clinical testing | IRF3: BS1 |
Breakthrough Genomics, |
RCV000891824 | SCV005209872 | likely benign | not provided | criteria provided, single submitter | not provided | ||
OMIM | RCV000585897 | SCV000693865 | risk factor | Encephalopathy, acute, infection-induced (herpes-specific), susceptibility to, 7 | 2018-03-14 | no assertion criteria provided | literature only | |
Prevention |
RCV003925756 | SCV004744618 | likely benign | IRF3-related disorder | 2020-03-16 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |